LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN (Octinoxate and Titanium Dioxide) by L'Oreal USA Products Inc: new human otc drug listing
LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN: new human otc drug listing. Dated 41 days ago, it serves as a historical benchmark. Score 15/100. As of 2026-11-04, from U.S. FDA National Drug Code (NDC) Directory via openFDA.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Free preview: all 12 published fields of this record are shown below. Locked: 499 related FdaNdcDirectoryPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Product | LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN |
| Generic name | Octinoxate and Titanium Dioxide |
| NDC | 82046-155 |
| Labeler | L'Oreal USA Products Inc |
| Product type | HUMAN OTC DRUG |
| Approval pathway | OTC MONOGRAPH DRUG |
| Application number | M020 |
| Dosage form | LIQUID |
| Route | TOPICAL |
| Active ingredients | OCTINOXATE 67 mg/mL; TITANIUM DIOXIDE 36 mg/mL |
| Marketing start | 2026-09-25 |
| Package configurations | 1 |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL
- Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
- Record date: 2026-09-25
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top FdaNdcDirectoryPulse records (HUMAN OTC DRUG first): Dove (Clinical and Sleep Shield Vanilla Dream Underarm Antip · ZKBB ECZEMA (Allantoin) by Guchutang Biotechnology (Longyan) · ZKBB WART REMOVER (Salicylic acid) by Guchutang Biotechnolog · ZKBB WART REMOVER (Salicylic Acid) by Guchutang Biotechnolog · ARNICA BRUISE (Arnica montana) by Shenzhen Fanyi Era Technol · Browse all by state and category →
LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Wed, 04 Nov 2026 18:12:05 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN and 2,418 HUMAN OTC DRUG peers
- HUMAN OTC DRUG FdaNdcDirectoryPulse records like this one: 2,418
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every HUMAN OTC DRUG peer: $483,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
15 / 100 Launch Signal Score
What is the FdaNdcDirectoryPulse record for LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN?
LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN by L'Oreal USA Products Inc: new human otc drug listing (OTC MONOGRAPH DRUG) starting 2026-09-25.
How does LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN compare to other FdaNdcDirectoryPulse records?
It is 41 days old, still within a typical 45-day follow-up window. Its Launch Signal Score of 15/100 is modest; treat it as background rather than a priority.
LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN vs. top 3 peers
| Organization | Location | Record date | Compare |
|---|---|---|---|
| LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN | HUMAN OTC DRUG | 2026-09-25 | This record |
| BRYTLY | HUMAN OTC DRUG | 2026-10-16 | Compare LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN vs BRYTLY → |
| OMEPRAZOLE | HUMAN OTC DRUG | 2026-09-11 | View record → |
| Nicotine Transdermal System step 1 | HUMAN OTC DRUG | 2026-09-01 | View record → |
Related records
FdaNdcDirectoryPulse: Over the counter (OTC) FdaNdcDirectoryPulse: OTC monograph
How to monitor LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN and peer otc monograph records
Get new FdaNdcDirectoryPulse records like LANCOME PARIS TEINT IDOLE ULTRA WEAR BROAD SPECTRUM SPF 25 BREATHABLE COVERAGE FOUNDATION SUNSCREEN by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.